Trial no.:
|
PACTR201403000785219 |
Date of Approval:
|
07/03/2014 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Effect of Gum Arabic on Type 2 Diabetes Mellitus |
Official scientific title |
Effect of Gum Arabic (Acacia Senegal) consumption on adipokine level, metabolic syndrome elements and inflammatory cytokines among Type 2 Diabetes Mellitus patients |
Brief summary describing the background
and objectives of the trial
|
Dibetes mellitus type 2 is a metabolic disorder of multiple aetiology characterized by peripheral insulin resistance and hyperinsulinaemia causing hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism as a result of defects of insulin secretion, its action or a combination of the two.In 1999 diagnostic criteria for diabetes was updated and modified by the World Health Organisation.Type 2 diabetes is commonly associated with a triad of medical disorders, these being obesity, hyperlipidaemia and hypertension, which have collectively become known as the ¿metabolic syndrome¿ or ¿syndrome X¿.Recent evidence indicates that inflammatory cytokines are elevated in patients with metabolic syndrome,thus suggesting a role for chronic inflammation as an underlying mechanism for progression of this disease. Various adipocyte-secreted factors have been described which profoundly affect insulin sensitivity and might potentially link obesity, insulin resistance, and cardiovascular diseaseGum Arabic was evaluated for acceptable daily intake for man by the Joint FAO/WHO Expert Committee on Food Additives since 1969. Several epidemiological studies suggest that a high intake of dietary fiber, including GA, is associated with beneficial effects on fat metabolism.Therefore a great opportunity for Gum Arabic to shift the equation of energy intake and utilization toward reduced fat storage holds to alter the course of human disease by the use of increasing range of adipocyte functions
Objectives
General objective
The Aim of this study is to assess the effects of supplemented Gum Arabic (GA) on adipocyte hormones among type 2 diabetes mellitus patients.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
GA Gum Arabic |
Disease(s) or condition(s) being studied |
Diabetes Mellitus Type 2,Nutritional, Metabolic, Endocrine |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Physical activity and nutrition |
Anticipated trial start date |
01/04/2014 |
Actual trial start date |
01/04/2014 |
Anticipated date of last follow up |
31/10/2014 |
Actual Last follow-up date |
30/09/2014 |
Anticipated target sample size (number of participants) |
200 |
Actual target sample size (number of participants) |
124 |
Recruitment status |
Completed |
Publication URL |
|
|